Stevens First Principles Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-17
Closed -$3K 178
2018
Q1
$3K Hold
17
﹤0.01% 142
2017
Q4
$3K Hold
17
﹤0.01% 177
2017
Q3
$3K Hold
17
﹤0.01% 165
2017
Q2
$4K Hold
17
﹤0.01% 161
2017
Q1
$4K Sell
17
-3
-15% -$699 ﹤0.01% 152
2016
Q4
$4K Hold
20
﹤0.01% 157
2016
Q3
$5K Buy
20
+3
+18% +$733 ﹤0.01% 139
2016
Q2
$4K Hold
17
﹤0.01% 131
2016
Q1
$5K Buy
+17
New +$4.87K ﹤0.01% 128
2015
Q3
Sell
-1,200
Closed -$364K 243
2015
Q2
$364K Buy
+1,200
New +$358K 0.24% 67

Other funds holding AGN

Stevens First Principles Investment Advisors's AGN Position: Q2 2018 in Review

Stevens First Principles Investment Advisors sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 17 shares — an estimated $3K sold.

Stevens First Principles Investment Advisors first reported a position in AGN in Q2 2015 and held it in 10 quarters. The position peaked at $364K in Q2 2015. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Stevens First Principles Investment Advisors reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Stevens First Principles Investment Advisors sold 17 Allergan plc shares in Q2 2018, an estimated $3K.
  • Stevens First Principles Investment Advisors first reported a position in Allergan plc in Q2 2015 and held it in 10 quarters.
  • Stevens First Principles Investment Advisors's Allergan plc position peaked at $364K in Q2 2015.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Stevens First Principles Investment Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.